| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/05/2009 | EP2083862A2 Compositions and methods for treating ocular diseases and conditions |
| 08/05/2009 | EP2083861A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083860A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083859A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083858A2 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 08/05/2009 | EP2083845A2 Ablative immunotherapy |
| 08/05/2009 | EP2021799A4 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
| 08/05/2009 | EP1758929A4 Methods for altering protein production rates |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1499887B1 Universal libraries for immunoglobulins |
| 08/05/2009 | EP1283265B1 Process for producing protein with reduction of mannose phosphate in the sugar chain and glycoprotein produced thereby |
| 08/05/2009 | EP1210115B1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/05/2009 | EP1069907B1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 08/05/2009 | EP1029054B1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/05/2009 | EP0981614B1 Prostate cancer-specific marker |
| 08/05/2009 | EP0960935B1 Novel mouse cxc chemokine receptor |
| 08/05/2009 | EP0938553B1 Dna encoding dp-75 and a process for its use |
| 08/05/2009 | EP0915980B1 Characterization of granulocytic ehrlichia and methods of use |
| 08/05/2009 | CN101501501A Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma |
| 08/05/2009 | CN101501208A Glyceroglycolipid antigen of mycoplasma pneumoniae |
| 08/05/2009 | CN101501195A Nitrogen limitation adaptibility gene and protein and modulation thereof |
| 08/05/2009 | CN101501074A Antigenic surface structure of sperm cells associated with the Y chromosome |
| 08/05/2009 | CN101501073A Method for producing antibodies |
| 08/05/2009 | CN101501072A Antibody molecules which bind human IL-17 |
| 08/05/2009 | CN101501071A Immune-derived moieties reactive against lysophosphatidic acid |
| 08/05/2009 | CN101501070A Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 08/05/2009 | CN101500592A Compositions and methods for controlling tissue factor signaling specificity |
| 08/05/2009 | CN101498731A Human monoclonal antibody against a costimulatory signal transduction molecule ATLIM and pharmaceutical use thereof |
| 08/05/2009 | CN101498728A Reagent kit for detecting o-allyl phenol and its special antibody |
| 08/05/2009 | CN101497909A Method for preparing anti-A type botulinus toxin immunoglobulin antibody |
| 08/05/2009 | CN101497665A Human fiber plasminogen Kringle5 polyclonal antibody, and preparation and use thereof |
| 08/05/2009 | CN101497664A Monoclonal antibody of human carboxypeptidase A inhibition factor Latexin and use thereof |
| 08/05/2009 | CN101497663A Antibody, method and reagent kit for detecting and determining baicalin |
| 08/05/2009 | CN101497662A TM4SF3 protein for preparing antineoplastic antibody and use thereof |
| 08/05/2009 | CN100523809C Vaccine for preventing pneumococus infection |
| 08/05/2009 | CN100523192C Vaccines from infectious agents |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100523176C Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 08/05/2009 | CN100522999C Anti-CD20 antibodies and fusion proteins thereof and methods of use |
| 08/05/2009 | CN100522998C Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 08/05/2009 | CN100522994C Discrimination between GnRH-I and GnRH-II |
| 08/05/2009 | CN100522989C Method of purifying protein |
| 08/05/2009 | CN100522242C Artificial proteins with reduced immunogenicity |
| 08/04/2009 | US7569744 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 08/04/2009 | US7569683 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 08/04/2009 | US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 08/04/2009 | US7569677 Antibiotic-conjugated antibodies |
| 08/04/2009 | US7569676 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 08/04/2009 | US7569675 High affinity monoclonal antibody for recognizing the progesterone receptor (PR) and method for creating the antibody |
| 08/04/2009 | US7569674 Autophilic antibodies |
| 08/04/2009 | US7569673 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
| 08/04/2009 | US7569672 Antibodies that bind to EphA2 and methods of use thereof |
| 08/04/2009 | US7569666 Polypeptides associated with activatory receptors and their biological applications |
| 08/04/2009 | US7569665 Comprises von willebrand factor a-related protein for use as diagnostic toll in diagnosis of autoimmune, arthritic and bone disorders |
| 08/04/2009 | US7569660 Recombinant prion-like proteins and materials comprising same |
| 08/04/2009 | US7569547 Inhibiting furin with polybasic peptides |
| 08/04/2009 | US7569542 can be produced recombinantly using bacterial, yeast, or eukaryotic cell expression system, without having to deal with problems associated with chemical or physical linkages |
| 08/04/2009 | US7569541 Malaria vaccine; cyclic peptidomimetics obtainable by these methods which are conformationally constrained due an internal cross-link between 4-aminoproline and glutamine, and having a central (Asn-Pro-Asn-Ala) |
| 08/04/2009 | US7569537 Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of Mycobacterium tuberculosis |
| 08/04/2009 | US7569392 Multiplex spatial profiling of gene expression |
| 08/04/2009 | US7569390 Selection of intracellular immunoglobulins |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569386 Chondroitin synthase gene and methods of making and using same |
| 08/04/2009 | US7569364 Anti-NGF antibodies and methods using same |
| 08/04/2009 | US7569362 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 08/04/2009 | US7569356 Detecting the presence of a prostate cancer cell expressing a protein SGP28; immunoassay |
| 08/04/2009 | US7569224 Mammalian cytokines; receptors; related reagents and methods |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 07/30/2009 | WO2009094551A1 Ferroportin antibodies and methods of use |
| 07/30/2009 | WO2009094391A1 Optimized cd40 antibodies and methods of using the same |
| 07/30/2009 | WO2009094148A2 Ron antibodies and uses thereof |
| 07/30/2009 | WO2009094006A2 Bordetella outer-membrane protein antigens and methods of making and using the same |
| 07/30/2009 | WO2009093998A1 NATURALLY OCCURING IgM ANTIBODIES THAT BIND LYMPHOCYTES |
| 07/30/2009 | WO2009093263A1 A humanized high affinity recombinant antibody against hepatitis b surface antigen |
| 07/30/2009 | WO2009093246A2 Clusterin derived peptide |
| 07/30/2009 | WO2009093138A1 Humanized antibodies specific for von willebrand factor |
| 07/30/2009 | WO2009092806A2 Selective exosite inhibition of papp-a activity against igfbp-4 |
| 07/30/2009 | WO2009092805A1 Humanized anti-human nkg2a monoclonal antibody |
| 07/30/2009 | WO2009092732A1 Proteinaceous binding molecules comprising purification tags or inert variable domains |
| 07/30/2009 | WO2009075881A3 Impaired wound healing compositions and treatments |
| 07/30/2009 | WO2009073805A3 Aglycosylated therapeutic antibodies and therapeutic antibody-encoding nucleotide sequences |
| 07/30/2009 | WO2009071892A3 Method for the detection of dead and dying cells |
| 07/30/2009 | WO2009064854A3 Humanized antibodies against tl1a |
| 07/30/2009 | WO2008150946A8 HUMANIZED ANTIBODIES WHICH BIND TO Aβ (1-42) GLOBULOMER AND USES THEREOF |
| 07/30/2009 | WO2008145754A3 Ligands of hvem for treating hematologic malignancies and autoimmune diseases |
| 07/30/2009 | WO2008125733A8 Immunoassay for quantification of an unstable antigen selected from bnp and probnp |
| 07/30/2009 | WO2008119882A8 Screening methods based on human adam12 polypeptide and binding agents thereof |
| 07/30/2009 | WO2008119353A8 Bispecific antibodies and methods for production thereof |
| 07/30/2009 | WO2008107523A8 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins |
| 07/30/2009 | WO2008087254A8 Method for detection of human immunodeficiency virus |
| 07/30/2009 | WO2008079359A8 Human antibodies that bind human il-12 and methods for producing |
| 07/30/2009 | WO2008067223A8 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 07/30/2009 | WO2007092772A8 Protein formulations |
| 07/30/2009 | US20090193530 Animals, cells and methods for production of detectably-labeled antibodies |
| 07/30/2009 | US20090193529 Method for Generating Antibodies |
| 07/30/2009 | US20090192295 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 07/30/2009 | US20090192294 Magi polynucleotides, polypeptides, and antibodies |
| 07/30/2009 | US20090192293 Antibodies to non-functional p2x7 receptor |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |